Ansell HY FY25 Results Presentation

Open PDF
Stock Ansell Ltd (ANN.ASX)
Release Time 10 Feb 2025, 7:47 a.m.
Price Sensitive Yes
 Ansell Reports Strong H1 FY25 Results
Key Points
  • Double-digit organic constant currency sales and earnings growth
  • KBU acquisition integration progressing ahead of plan
  • Accelerated Productivity Investment Program on track to deliver $45m in FY25 savings
  • Increasing FY25 Adjusted EPS guidance range
Full Summary

Ansell Ltd reported strong financial results for the first half of FY25, with double-digit organic constant currency growth in sales, EBIT and Adjusted EPS. The company's Industrial and Healthcare segments both delivered robust performance, with the Industrial segment benefiting from new product sales and the Healthcare segment recovering from destocking and fulfilling delayed FY24 orders. The acquisition of the KBU PPE business from Kimberly-Clark Corporation is progressing ahead of the initial business case, with 7.4% organic constant currency sales growth and 22.1% EBIT growth in FY25 H1. Ansell's Accelerated Productivity Investment Program is on track to deliver $45m in savings this fiscal year, with $22m achieved in the first half. The company has increased its FY25 Adjusted EPS guidance range to US118¢ to US128¢. Ansell continues to invest in long-term growth and differentiation, including a new customer-focused organizational structure, sharpened emerging markets focus, and expanded AnsellGUARDIAN service offerings. The company's global, diversified supply chain and sustainability initiatives also support its growth strategy.

Guidance

Ansell has increased its FY25 Adjusted EPS guidance range to US118¢ to US128¢.